Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kelley L Ratermann"'
Autor:
Patrick W. Burke, Stephen M Clark, Marissa Olson, Tapan M. Kadia, Dale L. Bixby, Carissa Treptow, Shawn Griffin, Bernard L. Marini, Kelley L Ratermann, Caitlin R. Rausch, Lydia L. Benitez, Mallory Crain, Anthony J. Perissinotti, Kristen Pettit, Michael Filtz, Jeff Klaus
Publikováno v:
Leukemia & Lymphoma. 62:2184-2192
Liposomal daunorubicin/cytarabine (CPX-351) gained FDA approval for secondary AML after demonstrating improved outcomes over daunorubicin and cytarabine (7 + 3). A number of study limitations prompted a comparison of safety/efficacy of CPX-351 agains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::908a11e5473e93f98a4ea728107e8325
https://doi.org/10.1080/10428194.2021.1907378
https://doi.org/10.1080/10428194.2021.1907378
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 4, Iss 1 (2015)
**Background:** Individuals with cancer are at an increased risk of venous thromboembolism (VTE). There is a continued increased risk of recurrent VTE after the initial event as well as increased bleed risk related to VTE treatment. **Objectives:**
Externí odkaz:
https://doaj.org/article/52b94d5a363c4ceb9e7123ab71c00c74
Publikováno v:
Journal of Neuro-Oncology. 135:593-599
The novel anti-mitotic based tumor treating fields (TTFields) is FDA approved for recurrent glioblastoma. Recently the phase III upfront trial combining the Novo TTF-100A device, called Optune, with temozolomide following concurrent radiation therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0739438ea8e93ee191fe09022a88d42b
https://doi.org/10.1007/s11060-017-2612-8
https://doi.org/10.1007/s11060-017-2612-8
Autor:
Mahesh Kudrimoti, Terri Pollack, Gaurav Goel, Ching Wei D. Tzeng, Philip A. DeSimone, Arturo Loaiza-Bonilla, Lowell Anthony, Muhammad Husnain, Shawn Lanham Peterson, Colleen Westendorf-Overley, Peter J. Hosein, Sean P. Dineen, Agustin Pimentel, Kelley L. Ratermann
Publikováno v:
Anticancer Res
Background/aim Combination nab-paclitaxel/gemcitabine (AG) is superior to gemcitabine in patients with metastatic pancreatic cancer (PC). There are limited data for AG in borderline resectable (BR) or locally advanced pancreatic cancer (LAPC). Herein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67b8ad24655367429f5670834f1522f2
https://europepmc.org/articles/PMC9375526/
https://europepmc.org/articles/PMC9375526/
This chapter serves as a review of publications in 2017 pertaining to new or unique adverse drug events associated with cytokines and monoclonal antibodies. Case reports and large trials detailing such previously unknown adverse effects are summarize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b863b53e61d807af861e4f0f8a04903
https://doi.org/10.1016/bs.seda.2018.07.010
https://doi.org/10.1016/bs.seda.2018.07.010
Autor:
Anthony J. Perissinotti, Carissa Treptow, Stephen M Clark, Patrick W. Burke, Kelley L Ratermann, Bernard L. Marini, Michael Filtz, Jeff Klaus, Kristen Pettit, Dale L. Bixby, Lydia L. Benitez, Caitlin R. Rausch, Shawn Griffin, Mallory Crain, Marissa Olson
Publikováno v:
Blood. 134:2639-2639
BACKGROUND Secondary AML (sAML) that develops after an antecedent hematologic disorder or exposure to genotoxic therapy is associated with a poor prognosis and historical long-term survival rates of 5-10% (Granfeldt Østgård et al. 2015). Liposomal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::110b27f44739d30464e7cb55ae7e3672
https://doi.org/10.1182/blood-2019-122189
https://doi.org/10.1182/blood-2019-122189
Autor:
Benjamin Ereshefsky, Elise L. Fleishaker, Kelley L. Ratermann, Craig A. Martin, Ketan P. Buch, Alice C. Thornton
Publikováno v:
The Annals of pharmacotherapy. 48(9)
Objective: To report on invasive aspergillosis infection in an immunocompetent adult after a near-drowning event, which allowed this pathogen to easily gain access to the human respiratory system and result in rapid, severe infection. Case Summary: A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58beeb67a7872e0ea471b42555a9573b
https://pubmed.ncbi.nlm.nih.gov/24939635
https://pubmed.ncbi.nlm.nih.gov/24939635